curacle
At a glance
curacle filed 27 disclosures in the last 12 months, including 6 insider. The most recent key filing was on Jun 10.
Revenue for 2025 was ₩7.1M, down 99.6% on 2024. It made an operating loss of ₩16.5B. Debt was 43% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩8.2B and operating loss of ₩640.7M.
The 2025 annual report lists 31 employees with an average tenure of 4.2 years and average pay of ₩81.9M. Its 7 directors and auditors were paid ₩240M each on average. It paid no cash dividend for 2025. 권영근 and related parties held 8.93% at year end.
From the 2025 annual report
Staff: 31 (17 men, 14 women), of whom 0 on fixed-term contracts. Total pay for the year: ₩2.6B. Directors and auditors: 7, paid ₩858M in total.
No cash dividend was paid for 2025.
Largest shareholder
권영근 holds 8.62%; with 2 related parties the group holds 8.93% of common shares at year end (from 13.33% at the start of the year).
Auditor: 다산회계법인 · opinion: Unqualified.
Source: 2025 annual business report (DART). How figures are combined
Financial summary
Key filings
Other filings
Links open the original filing on DART, in Korean.